{"id":"W2134392974","doi":"10.1200/jco.2012.48.3552","title":"Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":494,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; BC Cancer Agency; Novartis Pharma; Chugai Pharmaceutical; Ruijin Hospital; Hebei Medical University; Nanfang Hospital; Institut Gustave-Roussy; School of Medicine, Shanghai Jiao Tong University; Peking University; KU Leuven; Sichuan University; Universitair Ziekenhuis Gent; Sun Yat-sen University; China Medical University; Fudan University; McGill University; Sir Run Run Shaw Hospital; Shanghai Jiao Tong University; Harbin Medical University; Sanofi; Soochow University; GlaxoSmithKline","keywords":"Everolimus; Medicine; Ramucirumab; Internal medicine; Hazard ratio; Clinical endpoint; Adverse effect; Cancer; Placebo; Phases of clinical research; Gastroenterology; Chemotherapy; Surgery; Oncology; Clinical trial; Confidence interval; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003137307,0.001095423,0.002471832,0.000260737,0.0003263963,0.0008135759,0.0006189505,0.001193891,0.002621279],"category_scores_gemma":[0.001689755,0.0005006262,0.001777198,0.0002976002,0.0007201264,0.0007015694,0.0002796655,0.001903643,0.0004549192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005131214,"about_ca_system_score_gemma":0.0009734228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004276971,"about_ca_topic_score_gemma":0.001080172,"domain_scores_codex":[0.9992459,0.0004487609,0.00005601135,0.0000991426,0.00008607055,0.00006409521],"domain_scores_gemma":[0.9989586,0.0002383188,0.0003280789,0.00008668264,0.000064338,0.0003239571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9392632,0.01103908,0.003579217,0.0007472677,0.003219701,0.00007320647,0.00006480973,0.0005290996,0.00674805,0.00007468004,0.001534689,0.03312713],"study_design_scores_gemma":[0.9085045,0.07648528,0.01096844,0.00005063107,0.001338884,0.00009931828,0.00001367574,0.0003516584,0.0008103568,0.00006863953,0.001291831,0.00001684765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815785,0.01291344,0.0007353368,0.0005955246,0.0003049918,0.001786731,0.0008135238,0.0001064652,0.001165539],"genre_scores_gemma":[0.9841706,0.007238067,0.001361375,0.001317501,0.0005449475,0.002013472,0.001744527,0.00003750718,0.001572039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003137307,"threshold_uncertainty_score":0.01659185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1285665799292115,"score_gpt":0.4762735821499621,"score_spread":0.3477070022207507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}